Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

1.31
+0.03002.34%
Post-market: 1.320.0117+0.89%19:59 EDT
Volume:548.95K
Turnover:698.67K
Market Cap:8.64M
PE:-0.67
High:1.35
Open:1.27
Low:1.22
Close:1.28
52wk High:6.25
52wk Low:0.6200
Shares:6.59M
Float Shares:6.33M
Volume Ratio:0.22
T/O Rate:8.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9543
EPS(LYR):-2.5200
ROE:-77.88%
ROA:-47.32%
PB:1.00
PE(LYR):-0.52

Loading ...

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

GlobeNewswire
·
Jun 22

Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase

Reuters
·
Jun 16

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

GlobeNewswire
·
Jun 16

Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate

Benzinga Earnings
·
May 09

Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26

Reuters
·
May 09

Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
May 06

Creative Medical knee data ‘highly positive,’ says Roth Capital

TIPRANKS
·
Apr 28

Creative Medical reports pilot study of Ultrasome meets priamry endpoint

TIPRANKS
·
Apr 28

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

GlobeNewswire
·
Apr 28

Creative Medical Technology FY 2025 net loss rises 9% to USD 6 million on revenue down 46% to USD 6,000

Reuters
·
Mar 21

Creative Medical Technology Holdings Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
Mar 11